Strides Arcolab’s arm receives ‘International Headquarters Status’

13 Jan 2015 Evaluate

Strides Arcolab’s wholly owned subsidiary - Strides Pharma Global, Singapore (Strides Pharma Global) has been awarded ‘International Headquarters Status’ by the Singapore Economic Development Board (EDB). Strides Pharma Global proposes to carry out activities for its international business including business development and planning, sales and marketing, intellectual property management, global supply chain management and global regulatory affairs.

Strides Pharma Global will also be building a new manufacturing facility in Singapore in the next couple of years with focus on the regulated and South East Asia markets.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

800.35 6.75 (0.85%)
28-Jan-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1609.85
Dr. Reddys Lab 1224.30
Cipla 1331.80
Zydus Lifesciences 896.60
Lupin 2132.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×